{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:54:51Z","timestamp":1787320491981,"version":"build-2736575974"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Plasmapheresis has been a therapeutic option in kidney diseases to eliminate disease-causing autoantibodies, circulating factors, and abnormal components involved in complement pathways. We aim to systematically review the effectiveness and adverse events associated with plasmapheresis and related apheresis therapies in treating kidney diseases in paediatric and adult populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched databases including EMBASE, CINAHL, PubMed, and Cochrane Central for studies from 2010 to October 2023. The search terms included terms related to glomerulonephritis treated with plasmapheresis. Outcomes included the patient\u2019s length of hospital stay, mortality, development of kidney failure, associated comorbidities, and adverse events. Risk of bias was assessed using the Newcastle\u2013Ottawa Scale, and meta-analyses were performed to calculate pooled adverse event rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 33 studies with 1363 participants were included. The pooled proportion of kidney failure was 26.36% (95% CI 17.38%\u201336.47%), and the rate of dialysis requirement was 30.43% (95% CI 14.80%\u201348.82%). The mortality rate was 10.86% (95% CI 9.12%\u201312.81%). Adverse events were reported in 31.03% (95% CI 12.78%\u201353.05%) of cases. Heterogeneity was significant for most outcomes. We also performed a literature review due to a lack of adequate studies regarding the use of plasmapheresis in lupus nephritis, multiple myeloma, and atypical haemolytic uremic syndrome, as well as the use of low-density lipoprotein apheresis in kidney diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Plasmapheresis has demonstrated remission in patients with kidney diseases, particularly in those with ANCA-associated vasculitis and FSGS. Based on the results of our systematic review, we discuss the use of plasmapheresis for treating glomerular diseases, atypical haemolytic uremic syndrome, other kidney diseases, and the usage of low-density lipoprotein apheresis. Further research is needed to improve patient outcomes and reduce complications, especially in paediatric populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf282","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T11:51:52Z","timestamp":1757505112000},"source":"Crossref","is-referenced-by-count":1,"title":["Indications and recent evidence for apheresis in children and adults with kidney diseases: a comprehensive review"],"prefix":"10.1093","volume":"18","author":[{"given":"Rupesh","family":"Raina","sequence":"first","affiliation":[{"name":"Akron Nephrology Associates at Cleveland Clinic Akron General Medical Center Department of Nephrology, , Akron, OH ,","place":["USA"]},{"name":"Akron Children\u2019s Hospital Department of Pediatric Nephrology, , Akron, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-6005","authenticated-orcid":false,"given":"Eugene Yu-hin","family":"Chan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The Chinese University of Hong Kong Department of Paediatrics, , Shatin ,","place":["Hong Kong SAR"]},{"name":"Paediatric Nephrology Centre, Hong Kong Children\u2019s Hospital , Kowloon Bay ,","place":["Hong Kong SAR"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3982-7118","authenticated-orcid":false,"given":"Jieji","family":"Hu","sequence":"additional","affiliation":[{"name":"Akron Nephrology Associates at Cleveland Clinic Akron General Medical Center Department of Nephrology, , Akron, OH ,","place":["USA"]},{"name":"College of Medicine, Northeast Ohio Medical University , Rootstown, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pujan","family":"Moradiya","sequence":"additional","affiliation":[{"name":"College of Medicine, Northeast Ohio Medical University , Rootstown, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce","family":"Pember","sequence":"additional","affiliation":[{"name":"College of Medicine, Northeast Ohio Medical University , Rootstown, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Khandelwal","sequence":"additional","affiliation":[{"name":"The Hospital for Sick Children Division of Nephrology, Department of Pediatrics, , Toronto ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Atrium Health, Levine Children\u2019s Hospital Department of Pediatric Nephrology, , Charlotte, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4365-2995","authenticated-orcid":false,"given":"Ali","family":"D\u00fczova","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Faculty of Medicine, Hacettepe University , Ankara ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinnari","family":"Vala","sequence":"additional","affiliation":[{"name":"Institute of Kidney Diseases and Research Centre & Gujarat University of Transplantation Sciences Department of Pediatric Nephrology, , Ahmedabad ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivekanand","family":"Jha","sequence":"additional","affiliation":[{"name":"George Institute for Global Health, UNSW , New Delhi , ; School of Public Health, Imperial College, London, UK; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-1359","authenticated-orcid":false,"given":"Olivia","family":"Boyer","sequence":"additional","affiliation":[{"name":"N\u00e9phrologie P\u00e9diatrique, Centre de R\u00e9f\u00e9rence du Syndrome N\u00e9phrotique Idiopathique de L\u2019enfant Et L\u2019adulte, H\u00f4pital Necker - Enfants Malades, APHP, Inserm U1163, Institut Imagine, Universit\u00e9 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-3393","authenticated-orcid":false,"given":"Sidharth","family":"Sethi","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Kidney Institute, Medanta, the Medicity Hospital , Gurgaon, Haryana ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Canetta","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Columbia University Irving Medical Center Department of Medicine, , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"2025101006163465500_bib1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s40124-022-00275-y","article-title":"Advances in apheresis techniques and therapies in the pediatric setting","volume":"10","author":"Hong","year":"2022","journal-title":"Curr Pediatr Rep"},{"key":"2025101006163465500_bib2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1046\/j.1526-0968.1999.00146.x","article-title":"Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstr\u00f6m\u2019s macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis","volume":"3","author":"Siami","year":"1999","journal-title":"Ther Apher"},{"key":"2025101006163465500_bib3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5500\/wjt.v9.i6.103","article-title":"Therapeutic apheresis in kidney transplantation: an updated review","volume":"9","author":"Salvadori","year":"2019","journal-title":"World J Transplant"},{"key":"2025101006163465500_bib4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apheresis"},{"key":"2025101006163465500_bib5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"KDIGO 2024 clinical practice guideline for the management of lupus nephritis","volume":"105","author":"Rovin","year":"2024","journal-title":"Kidney Int"},{"key":"2025101006163465500_bib6","doi-asserted-by":"publisher","first-page":"e13955","DOI":"10.1111\/petr.13955","article-title":"Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis\/steroid-resistant nephrotic syndrome","volume":"25","author":"Weber","year":"2021","journal-title":"Pediatr Transplant"},{"key":"2025101006163465500_bib7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"2025101006163465500_bib8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ekir.2022.10.014","article-title":"Long-term outcomes of children and adolescents with biopsy-proven childhood-onset lupus nephritis","volume":"8","author":"Chan","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2025101006163465500_bib9","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/ndt\/gfae009","article-title":"Outcome of immunosuppression in children with IgA vasculitis\u2013related nephritis","volume":"39","author":"Rohner","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2025101006163465500_bib10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2215\/CJN.08570722","article-title":"Use of rituximab in childhood idiopathic nephrotic syndrome","volume":"18","author":"Chan","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025101006163465500_bib11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1053\/j.ajkd.2022.10.017","article-title":"Therapeutic plasma exchange: core curriculum 2023","volume":"81","author":"Cervantes","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"2025101006163465500_bib12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00467-013-2479-7","article-title":"Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013","volume":"29","author":"Carter","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"2025101006163465500_bib13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1525-139X.2011.01028.x","article-title":"Therapeutic apheresis in children: special considerations","volume":"25","author":"Goldstein","year":"2012","journal-title":"Semin Dial"},{"key":"2025101006163465500_bib14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1053\/j.ajkd.2022.05.013","article-title":"Clinical factors and adverse kidney outcomes in children with antineutrophil cytoplasmic antibody-associated glomerulonephritis","volume":"81","author":"Marlais","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"2025101006163465500_bib15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0749-0704(01)00010-0","article-title":"Plasmapheresis","volume":"18","author":"Madore","year":"2002","journal-title":"Crit Care Clin"},{"key":"2025101006163465500_bib16","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2025101006163465500_bib17","doi-asserted-by":"publisher","first-page":"CD003232","DOI":"10.1002\/14651858.CD003232.pub4","article-title":"Interventions for renal vasculitis in adults","volume":"1","author":"Walters","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2025101006163465500_bib18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"2025101006163465500_bib19","doi-asserted-by":"publisher","first-page":"e064604","DOI":"10.1136\/bmj-2021-064604","article-title":"The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis","author":"Walsh","year":"2022","journal-title":"BMJ"},{"key":"2025101006163465500_bib20","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.34067\/KID.0000000000000496","article-title":"Plasmapheresis in ANCA-associated vasculitis with active kidney involvement in the United States (2016\u20132020): a cross-sectional study","volume":"5","author":"Tao","year":"2024","journal-title":"Kidney360"},{"key":"2025101006163465500_bib21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.ajkd.2023.12.019","article-title":"Use of immunoadsorption and plasma exchange for treating anti-glomerular basement membrane disease: clinical experience in Germany","volume":"84","author":"Von Samson-Himmelstjerna","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"2025101006163465500_bib22","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s40620-023-01695-9","article-title":"Therapeutic plasma exchange for anti-glomerular basement membrane disease with dialysis-dependent kidney failure without diffuse alveolar hemorrhage","volume":"36","author":"Watanabe","year":"2023","journal-title":"J Nephrol"},{"key":"2025101006163465500_bib23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2369-15-128","article-title":"Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis","volume":"15","author":"Zhang","year":"2014","journal-title":"BMC Nephrol"},{"key":"2025101006163465500_bib24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s10157-015-1218-8","article-title":"Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014","volume":"20","author":"Arimura","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"2025101006163465500_bib25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/MD.0b013e31822f6f68","article-title":"Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study","volume":"90","author":"Cui","year":"2011","journal-title":"Medicine"},{"key":"2025101006163465500_bib26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/j.akdh.2024.04.007","article-title":"Anti-glomerular basement membrane disease: recent updates","volume":"31","author":"Bharati","year":"2024","journal-title":"Adv Kidney Dis Health"},{"key":"2025101006163465500_bib27","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.3390\/jcm10215154","article-title":"Plasma exchange in ANCA-associated vasculitis: a narrative review","volume":"10","author":"Tsiakas","year":"2021","journal-title":"J Clin Med"},{"key":"2025101006163465500_bib28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.rmcr.2018.09.016","article-title":"Successful treatment of steroid-refractory double-positive ANCA and anti-GBM disease with a combination of plasma exchange and immunosuppression: a case report and literature review","volume":"25","author":"Uto","year":"2018","journal-title":"Respir Med Case Rep"},{"key":"2025101006163465500_bib29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5350\/SEMB.20170526055541","article-title":"Plasmapheresis experience in patients with acute kidney injury","author":"Sakaci","year":"2017","journal-title":"SiSli Etfal Hastan Tip Bul Med Bull Sisli Hosp"},{"key":"2025101006163465500_bib30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","article-title":"Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis","volume":"57","author":"Walsh","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2025101006163465500_bib31","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.3390\/ijms24043977","article-title":"Efficacy and safety of plasma exchange as an adjunctive therapy for rapidly progressive IgA nephropathy and henoch-sch\u00f6nlein purpura nephritis: a systematic review","volume":"24","author":"Nguyen","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025101006163465500_bib32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/MOT.0b013e3283402cf4","article-title":"Targeting B cells in sensitized kidney transplant patients: state of the art and future perspectives","volume":"15","author":"Snanoudj","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"2025101006163465500_bib33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000334155","article-title":"Plasmapheresis in immunologic renal disease","volume":"33","author":"Pusey","year":"2012","journal-title":"Blood Purif"},{"key":"2025101006163465500_bib34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/ajts.AJTS_5_19","article-title":"Role of therapeutic plasma exchange in acute humoral rejection patients undergoing live-related renal transplantation: a single-center experience","volume":"15","author":"Kakkar","year":"2021","journal-title":"Asian J Transfus Sci"},{"key":"2025101006163465500_bib35","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/jca.21897","article-title":"Treatment of antibody-mediated rejection with double-filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation","volume":"36","author":"Naciri Bennani","year":"2021","journal-title":"J Clin Apheresis"},{"key":"2025101006163465500_bib36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/TP.0b013e31825d1587","article-title":"The treatment of acute antibody-mediated rejection in kidney transplant recipients\u2014a systematic review","volume":"94","author":"Roberts","year":"2012","journal-title":"Transplantation"},{"key":"2025101006163465500_bib37","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.transproceed.2017.02.059","article-title":"Outcome of pretransplantation therapeutic plasma exchange in highly sensitized deceased-donor kidney transplant recipients","volume":"49","author":"Tipjaiaue","year":"2017","journal-title":"Transplant Proc"},{"key":"2025101006163465500_bib38","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/TP.0b013e3181da1cc3","article-title":"Combined posttransplant prophylactic IVIg\/Anti-CD 20\/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study","volume":"89","author":"Loupy","year":"2010","journal-title":"Transplantation"},{"key":"2025101006163465500_bib39","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/TP.0000000000002049","article-title":"The treatment of antibody-mediated rejection in kidney transplantation: an updated systematic review and meta-analysis","volume":"102","author":"Wan","year":"2018","journal-title":"Transplantation"},{"key":"2025101006163465500_bib40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2215\/CJN.08970719","article-title":"Recurrence of FSGS after kidney transplantation in adults","volume":"15","author":"Uffing","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025101006163465500_bib41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJM199401063300102","article-title":"Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome","volume":"330","author":"Dantal","year":"1994","journal-title":"N Engl J Med"},{"key":"2025101006163465500_bib42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1159\/000506277","article-title":"Extracorporeal therapies in the treatment of focal segmental glomerulosclerosis","volume":"49","author":"Raina","year":"2020","journal-title":"Blood Purif"},{"key":"2025101006163465500_bib43","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s11255-020-02462-6","article-title":"Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis","volume":"52","author":"Hansrivijit","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"2025101006163465500_bib44","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5500\/wjt.v11.i7.303","article-title":"Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: a systematic review and meta-analysis","volume":"11","author":"Boonpheng","year":"2021","journal-title":"World J Transplant"},{"key":"2025101006163465500_bib45","doi-asserted-by":"publisher","first-page":"1181076","DOI":"10.3389\/fneph.2023.1181076","article-title":"A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design","volume":"3","author":"Rheault","year":"2023","journal-title":"Front Nephrol"},{"key":"2025101006163465500_bib46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12882-016-0322-7","article-title":"The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: a systematic review and meta-analysis of 77 case-reports and case-series","volume":"17","author":"Kashgary","year":"2016","journal-title":"BMC Nephrol"},{"key":"2025101006163465500_bib47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/ndt\/gfp538","article-title":"Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation","volume":"25","author":"Ponticelli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2025101006163465500_bib48","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.ekir.2022.03.002","article-title":"Long-term apheresis in the management of patients with recurrent focal segmental glomerulosclerosis after kidney transplantation","volume":"7","author":"Uffing","year":"2022","journal-title":"Kidney Int Rep"},{"key":"2025101006163465500_bib49","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJM199205213262101","article-title":"A controlled trial of plasmapheresis therapy in severe lupus nephritis","volume":"326","author":"Lewis","year":"1992","journal-title":"N Engl J Med"},{"key":"2025101006163465500_bib50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/ckj\/sft150","article-title":"Plasma exchange for concurrent lupus nephritis and antiphospholipid syndrome","volume":"7","author":"Sendzischew","year":"2014","journal-title":"Clin Kidney J"},{"key":"2025101006163465500_bib51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"2025101006163465500_bib52","doi-asserted-by":"publisher","first-page":"e3595","DOI":"10.1097\/MD.0000000000003595","article-title":"Plasmapheresis is associated with better renal outcomes in lupus nephritis patients with thrombotic microangiopathy: a case series study","volume":"95","author":"Li","year":"2016","journal-title":"Medicine"},{"key":"2025101006163465500_bib53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1034\/j.1600-0609.2000.90221.x","article-title":"Renal failure in multiple myeloma: reversibility and impact on the prognosis","volume":"65","author":"Knudsen","year":"2000","journal-title":"Eur J Haematol"},{"key":"2025101006163465500_bib54","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000439239","article-title":"Hemodialysis using high cut off filters in light chain cast nephropathy","volume":"40","author":"Buus","year":"2015","journal-title":"Blood Purif"},{"key":"2025101006163465500_bib55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/1744-9987.12606","article-title":"Role of plasmapheresis in the management of acute kidney injury in patients with multiple myeloma: should we abandon it?","volume":"22","author":"Premuzic","year":"2018","journal-title":"Ther Apher Dial"},{"key":"2025101006163465500_bib56","doi-asserted-by":"publisher","first-page":"5415\u2013","DOI":"10.1182\/blood.V130.Suppl_1.5415.5415","article-title":"Plasmapheresis and myeloma cast nephropathy: a meta-analysis and review of evidence","volume":"130","author":"Alkhatib","year":"2017","journal-title":"Blood"},{"key":"2025101006163465500_bib57","doi-asserted-by":"publisher","first-page":"931210","DOI":"10.3389\/fimmu.2022.931210","article-title":"Anti-factor H antibody and its role in atypical hemolytic uremic syndrome","volume":"13","author":"Raina","year":"2022","journal-title":"Front Immunol"},{"key":"2025101006163465500_bib58","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3389\/fimmu.2019.01282","article-title":"Clinical and immunological profile of anti-factor H antibody associated atypical hemolytic uremic syndrome: a nationwide database","volume":"10","author":"Puraswani","year":"2019","journal-title":"Front Immunol"},{"key":"2025101006163465500_bib59","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00467-014-2948-7","article-title":"Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome","volume":"30","author":"Khandelwal","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"2025101006163465500_bib60","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/jca.21711","article-title":"Membrane-filtration based plasma exchanges for atypical hemolytic uremic syndrome: audit of efficacy and safety","volume":"34","author":"Khandelwal","year":"2019","journal-title":"J Clin Apheresis"},{"key":"2025101006163465500_bib61","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-014-2817-4","article-title":"An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome","volume":"29","author":"Johnson","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"2025101006163465500_bib62","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s00467-018-4061-9","article-title":"An update on LDL apheresis for nephrotic syndrome","volume":"34","author":"Raina","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"2025101006163465500_bib63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1100\/2012\/314283","article-title":"LDL-apheresis: technical and clinical aspects","volume":"2012","author":"Bambauer","year":"2012","journal-title":"Sci World J"},{"key":"2025101006163465500_bib64","volume-title":"Lipoprotein Apheresis","author":"Feingold","year":"2000"},{"key":"2025101006163465500_bib65","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11883-019-0787-5","article-title":"Current role of lipoprotein apheresis","volume":"21","author":"Thompson","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"2025101006163465500_bib66","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s10157-021-02098-5","article-title":"A digest of the evidence-based clinical practice guideline for nephrotic syndrome 2020","volume":"25","author":"Wada","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"2025101006163465500_bib67","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10157-014-1030-x","article-title":"Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy","volume":"19","author":"Ishikura","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"2025101006163465500_bib68","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.ekir.2021.04.029","article-title":"Apheresis in adult with refractory idiopathic nephrotic syndrome on native kidneys","volume":"6","author":"Moret","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2025101006163465500_bib69","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/01.CIR.93.10.1826","article-title":"LDL-apheresis atherosclerosis regression study (LAARS): effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis","volume":"93","author":"Kroon","year":"1996","journal-title":"Circulation"},{"key":"2025101006163465500_bib70","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fped.2019.00454","article-title":"Dextran-sulfate plasma adsorption lipoprotein apheresis in drug resistant primary focal segmental glomerulosclerosis patients: results from a prospective, multicenter, single-arm intervention study","volume":"7","author":"Raina","year":"2019","journal-title":"Front Pediatr"},{"key":"2025101006163465500_bib71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8926786","article-title":"Preoperative low-density lipoprotein apheresis for preventing recurrence of focal segmental glomerulosclerosis after kidney transplantation","volume":"2018","author":"Sannomiya","year":"2018","journal-title":"J Transplant"},{"key":"2025101006163465500_bib72","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000437338","article-title":"A prospective observational survey on the long-term effect of LDL apheresis on drug-resistant nephrotic syndrome","volume":"5","author":"Muso","year":"2015","journal-title":"Nephron Extra"},{"key":"2025101006163465500_bib73","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/1744-9987.13694","article-title":"Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function","volume":"26","author":"Muso","year":"2022","journal-title":"Ther Apher Dial"},{"key":"2025101006163465500_bib74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10157-007-0003-8","article-title":"Applications of LDL-apheresis in nephrology","volume":"12","author":"Kobayashi","year":"2008","journal-title":"Clin Exp Nephrol"},{"key":"2025101006163465500_bib75","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1056-8727(02)00171-X","article-title":"Effect of low-density lipoprotein apheresis on plasma endothelin-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans","volume":"17","author":"Nakamura","year":"2003","journal-title":"J Diabetes Complications"},{"key":"2025101006163465500_bib76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11883-021-00911-w","article-title":"LDL apheresis and Lp(a) apheresis: a clinician\u2019s perspective","volume":"23","author":"Kayikcioglu","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"2025101006163465500_bib77","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00467-019-04296-6","article-title":"LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients","volume":"34","author":"Shah","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"2025101006163465500_bib78","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.ekir.2024.04.026","article-title":"Emerging therapies for familial lecithin-cholesterol acyltransferase deficiency: a role for plasma exchange","volume":"9","author":"Ratnayake","year":"2024","journal-title":"Kidney Int Rep"},{"key":"2025101006163465500_bib79","doi-asserted-by":"publisher","first-page":"e0150083","DOI":"10.1371\/journal.pone.0150083","article-title":"Lipoprotein X causes renal disease in LCAT deficiency","volume":"11","author":"Ossoli","year":"2016","journal-title":"PLoS ONE"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf282\/64236450\/sfaf282.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/10\/sfaf282\/64236450\/sfaf282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/10\/sfaf282\/64236450\/sfaf282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:16:41Z","timestamp":1760091401000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf282\/8250628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":79,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf282","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,10]]},"article-number":"sfaf282"}}